BSEAGM/EGM29 Sept 2026 · 29 Sept 2026, 06:05 pm
PFA
Biogen Pharmachem Industries Ltd · 531752
✦ AI SummaryMgmt Change
Biogen Pharmachem Industries Ltd has informed about the outcome of its 31st Annual General Meeting (AGM) held on September 29, 2026, where the shareholders passed the ordinary resolutions for adoption of audited financial statements, re-appointment of a director, and appointment of statutory auditors.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Biogen Pharmachem Industries Ltd - 531752 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Attachments (1)
📄pdf
Download →
88af9bef-324a-4d52-8033-bc2f93bc17e3.pdf
View document text
BIOGEN
PHARMACHEM INDUSTRIES LIMITED
CIN NO: L51100GJ1995PLC026702 (Formerly Known as SUN TECHNO OVERSEAS LIMITED)
Date: 29.09.2026
Listing Department,
BSE Limited,
P J Tower, Dalal Street,
Mumbai-400001
Dear Sir/Madam,
Sub: Proceedings of 31st Annual General Meeting of the Company held on 29th September 2026.
In terms of Regulation 30 read with Part A of Schedule lll of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
("Listing Regulations"), we hereby inform you that the following businesses were transacted at the Annual General Meeting of the
Company held on Tuesday the 29th September 2026 at 04:00 P.M. through Video Conferencing (“VC”) / Other Audio Visual
Means (“OAVM”).
1. Ordinary Resolution for adoption of the audited financial statements of the Company for the Financial Year ended 31st March
2026 and Reports of the Directors and Auditors thereon.
2. Ordinary Resolution for re-appointment of Mr. Kelash Bunkar (DIN: 10911360), as director of the Company who retires by
rotation.
3. Ordinary Resolution for appointment of M/s. Goenka Mehta & Associates Chartered Accountants, Rajkot (Firm
Registration No: 129445W) as Statutory auditors and fix their remuneration.
The above businesses were transacted and passed by the shareholders at Annual General Meeting.
The AGM commenced at 04:00 P.M and concluded at 04:20 P.M.
Details of voting results as required under Regulation 44(3) of Listing Regulations are being submitted separately.
Kindly take note of the above.
Thanking you,
Yours faithfully,
For, BIOGEN PHARMACHEM INDUSTRIES LIMITED
KELASH BUNKAR
Wholetime Director
DIN: 09096576
Registered Office Address: Shop No. 8, First Floor, Makers – 1 Building, Jawahar Road, Rajkot-360001
E mail suntechnooverseas@gmail.com